- 1. X-AVI Video
- [The AVI file format is just a wrapper for many different codecs; it is a source of many interoperability problems. ( HL7V3.0 )] (UMLS (HL7) C1555001) =Idea or Concept =VideoMediaType;
| - 10. Xanthine Dehydrogenase Gene
- [This gene plays a role in the oxidative metabolism of purines. ( NCI )] (UMLS (NCI) C1421531) XDH;
XDH Gene =Gene or Genome |
- 2. XAF1
- [Widely expressed (highest in heart, ovary; lowest in brain, testis) by human XAF1 Gene (IAP Family), 317-aa 37-kDa XIAP-Associated Factor 1 contains 3 Cys-rich BIR domains (bind to and inhibit caspases), 7 zinc fingers, and a C-terminal RING zinc finger that possesses E3 ubiquitin ligase activity. Associated with nuclear redistribution of XIAP, cytoplasmic XAF1 appears to antagonize nuclear XIAP inhibition of CASP3 activity. (NCI) ( NCI )] (UMLS (NCI) C1447833) XIAP-Associated Factor 1;
ZAP-1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 11. Xanthine Oxidase Inhibitor
- [any substance or agent which suppresses, prevents or opposes the action of xanthine oxidase. ( CSP )] (UMLS (NCI) C0302609) =Organic Chemical; Pharmacologic Substance ;
=oxidoreductase inhibitor;
=1,5-Dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one |
- 3. Xalatan
- (UMLS (NCI) C0593887) =Organic Chemical; Pharmacologic Substance
| - 12. Xanthogranulomatous Cholecystitis
- (UMLS (NCI) C1337035) =Disease or Syndrome ;
|
- 4. Xaliproden Hydrochloride
- [The hydrochloride salt of xaliproden, an orally-active, synthetic, non-peptidic 5-HT1A receptor agonist with neurotrophic and neuroprotective properties. Although the mechanism of action of xaliproden is not fully understood, it appears to either mimic the effects of neurotrophins or stimulate their synthesis, thereby stimulating neuronal cell differentiation and proliferation and inhibiting neuronal cell death. Xaliproden's neuroprotective effect involves the activation of MAP kinase pathways via stimulation of the 5-HT1A receptor. ( NCI )] (UMLS (NCI) C1138236) =Organic Chemical; Pharmacologic Substance
| - 13. Xanthoma
- [A non-neoplastic disorder characterized by a localized collection of histiocytes containing lipid. Xanthomas usually occur in the skin and subcutaneous tissues, but occasionally they may involve the deep soft tissues. — 2003 ( NCI )] (UMLS (NCI) C0302314) =Disease or Syndrome
|
- 5. Xanax
- (UMLS (NCI) C0699034) =Organic Chemical; Pharmacologic Substance
| - 14. xanthoma tuberosum multiplex
- [ ] (UMLS (CSP) C0242165) =Disease or Syndrome
|
- 6. xanthelasmatosis
- [condition of morphologic change in which there is accumulation of lipids in the large foam cells of tissues; the cutaneous manifestation of lipidosis in which plasma fatty acids and lipoproteins are quantitatively changed. ( CSP )] (UMLS (CSP) C0043325) =Disease or Syndrome =Metabolic Disease;
Skin Diseases, Metabolic;
Alteracoes do metabolismo lipidico;
=Wolman Disease;
cerebrotendinous xanthomatosis;
Wolman Disease;
cerebrotendinous xanthomatosis | - 15. xanthomatous reticuloendotheliosis
- [ ] (UMLS (CSP) C0598603) =Neoplastic Process
|
- 7. xanthene
- [Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring. ( MSH )] (UMLS (CSP) C0043313) =Organic Chemical =Heterocyclic Compounds, 3-Ring;
=Fluoresceins;
Propantheline;
Thioxanthenes;
| - 16. Xanthomonas
- [A genus in the family XANTHOMONADACEAE whose cells produce a yellow pigment (Gr. xanthos - yellow). It is pathogenic to plants. ( MSH )] (UMLS (CSP) C0043327) =Bacterium
|
- 8. xanthine
- [2,6-dioxypurine; purine base found in most body tissues and fluids, certain plants, and some urinary calculi; it is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine; methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. ( CSP )] (UMLS (CSP) C0043318) =Organic Chemical; Biologically Active Substance ;
=Purinones;
oxypurine =1,3,7-trimethylxanthine;
theobromine;
3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione;
| - 17. xanthone
- [ ] (UMLS (CSP) C0078604) =Organic Chemical
|
- 9. xanthine analog
- [synthetic or natural chemical compounds which resemble xanthine in structure and/or function. ( CSP )] (UMLS (CSP) C0597693) =Organic Chemical ;
=purine analog;
| - 18. Xanthophylls
- [Oxygenated forms of carotenoids. They are usually derived from alpha and beta carotene. ( MSH )] (UMLS (NCI) C0949636) =Organic Chemical; Biologically Active Substance ;
|
home
